The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics.
WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version.
The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal.
WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%.
Browns' draft still affected by Deshaun Watson trade. Team without first
Xi Inspects Community in Nanning in China's Guangxi
France makes face mask mandatory in all indoor public places
Top of Eiffel Tower reopens to public
Missouri lawmakers back big expansion of low
France makes face mask mandatory in all indoor public places
NYC paints Black Lives Matter mural in front of Trump Tower
Merkel rejects calls for abolishing face mask requirement in German shops
Inside luxury brands' STAGGERING price hikes
Syrian workers arrange cotton fabric for making masks in Damascus